About Enfira 500 Mg
Discover the extraordinary value of Enfira 500 Mg, a renowned solution for infusion that delivers Rituximab 500 mg in a secure, glass bottle packaging of 50 ml. As a prescription-only medication, Enfira is famed for treating Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis. This clear, odorless infusion is specifically designed for IV use and must be protected from light. With unbeatable price offerings and a generous 24-month shelf life, get peace of mind knowing you have a premium monoclonal antibody from a trusted Indian supplier and trader.
Exceptional Surface Application and Infusion Features
Enfira 500 Mg is tailored for intravenous infusion, ensuring precise delivery directly into the bloodstream. The solution's neutral pH and clear, colorless-to-pale-yellow appearance underscore its premium formulation. This monoclonal antibody product is suitable for clinical settings requiring advanced therapeutic interventions against serious conditions, with glass bottle packaging enhancing its integrity. For healthcare providers seeking consistent, reliable IV infusions, Enfira offers a superior combination of safety, efficacy, and user convenience.
Domestic Reach, Packaging Excellence, and Sample Policy
Enfira 500 Mg is widely available across the main domestic market in India. Packaged thoughtfully in durable glass bottles for enhanced product safety, our freight and drop-off services ensure prompt and secure delivery. Packaging takes into account the need for temperature-controlled storage and light protection. We offer a flexible sample policy to support clinical institutions and pharmacies in evaluating this product, ensuring your procurement aligns with the highest standards in infusion solutions.
FAQ's of Enfira 500 Mg:
Q: How should Enfira 500 Mg be stored and handled?
A: Enfira 500 Mg must be stored in a refrigerator between 2C and 8C, away from light. Handle the glass bottle carefully to maintain its integrity and ensure the solution remains clear and colorless.
Q: What conditions is Enfira 500 Mg prescribed for?
A: Enfira 500 Mg is indicated for the treatment of Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis, administered only under prescription and healthcare supervision.
Q: When is Enfira 500 Mg administered during the treatment process?
A: Enfira 500 Mg is used as part of scheduled treatment regimens as determined by a medical professional. The frequency and duration depend on the specific indication and patient condition.
Q: Where can Enfira 500 Mg be applied?
A: This medication is suitable exclusively for use in healthcare settings, specifically for intravenous infusions performed by trained professionals.
Q: What are the features and benefits of Enfira 500 Mg?
A: Enfira 500 Mg boasts a neutral pH, is clear and odorless, and comes in secure glass bottle packaging. As a reputable monoclonal antibody, it offers reliable performance and safety, with a shelf life of 24 months.
Q: How is Enfira 500 Mg supplied and packaged for delivery?
A: Each unit is supplied in a 50 ml glass bottle, carefully packaged for stability during freight and drop-off. Packaging safeguards the medication from temperature fluctuations and light exposure.